Literature DB >> 11566843

Removal of thioridazine from primary care formulary will result in prescribing vacuum.

N Wright.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11566843      PMCID： PMC1121250          DOI： 10.1136/bmj.323.7314.695

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients.

Authors:  J G Reilly; S A Ayis; I N Ferrier; S J Jones; S H Thomas
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321
  1 in total
  2 in total

1.  Impact of the CSM advice on thioridazine on general practitioner prescribing behaviour in Leeds: time series analysis.

Authors:  Nat M J Wright; Alison J Roberts; Victoria L Allgar; Charlotte N E Tompkins; Darren C Greenwood; Gillian Laurence
Journal:  Br J Gen Pract       Date:  2004-05       Impact factor: 5.386

2.  Repeated dosing with donepezil does not affect the safety, tolerability or pharmacokinetics of single-dose thioridazine in young volunteers.

Authors:  Miroslav Ravic; Steve Warrington; Malcolm Boyce; Kate Dunn; Atholl Johnston
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.